Aug 5 (Reuters) - Noxopharm Ltd (NOX) : VEYONDA SURVIVAL ADVANTAGE IN LUPSMA THERAPY CONFIRMED ANIMAL STUDY SHOWS ADDING VEYONDA TO 177LUTETIUM-PSMA-617 RESULTS IN REGRESSION OF PROSTATE CANCER